NEW YORK - Immunocore yavuze ko ku wa mbere izagurisha imigabane 3,733.333 mu masezerano yo gutera inkunga abikorera ku giti cyabo (PIPE) biteganijwe ko azakusanya miliyoni 140 z'amadolari.

NEW YORK - Immunocore yavuze ko ku wa mbere izagurisha imigabane 3,733.333 mu masezerano yo gutera inkunga abikorera ku giti cyabo (PIPE) biteganijwe ko azakusanya miliyoni 140 z'amadolari.
Muri aya masezerano, Immunocore izagurisha imigabane isanzwe hamwe no kudatora imigabane isanzwe ku madolari 37.50 kuri buri mugabane. Abashoramari bari basanzwe bitabiriye gutera inkunga harimo ishoramari rya RTW, Rock Springs Capital na General Atlantike. Biteganijwe ko amasezerano ya PIPE azarangira ku ya 20 Nyakanga.
Isosiyete izakoresha amafaranga yavuye mu gutera inkunga abakandida bayo ba oncology n’indwara zandura, harimo no guteza imbere umukandida wayo wa mbere w’indwara ya oncologiya, Kimmtrak (tebentafusp-tebn), kugira ngo bavure uruhu rwiza rwa HLA-A * 02: 01 na uveal melanoma.
Uyu mwaka, Kimmtrak yemerewe gukoreshwa mu barwayi barwaye HLA-A * 02: 01 nziza itavurwa neza cyangwa metastatike uveal melanoma muri Amerika, Uburayi n'Ubwongereza, mu bindi bihugu.Immunocore ikomeje kwiga ibiyobyabwenge mu cyiciro cya I / II muri HLA-A * 02: 01-nziza ya melanoma.
Immunocore kandi irimo guteza imbere abandi bakandida bane ba oncologiya, harimo imiti ibiri y’inyongera ya T-selile yakira mu cyiciro cya I / II mu ibibyimba bikomeye byateye imbere. Kimwe mu biyobyabwenge kirimo gutegurwa ku barwayi ba HLA-A * 02: 01-cyiza na MAGE-A4, naho ibindi byibasira HLA-A * 02: 01 hamwe n’ibibyimba biteza imbere PRAME.
Politiki Yibanga.ibisabwa. Uburenganzira © 2022 GenomeWeb, ishami ryubucuruzi ryitumanaho rya Crain.uburenganzira bwose burasubitswe.


Igihe cyo kohereza: Nyakanga-30-2022